REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
D. E. Shaw & Co., Inc. 782,016$8,969,7240.01%
Invesco Ltd. 2,902,440$33,290,9860.01%
Walleye Capital LLC 305,792$3,507,4340.01%
PRINCIPAL FINANCIAL GROUP INC 963,029$11,045,9350.01%
China Universal Asset Management Co., Ltd. 2,250$260.01%
Yarbrough Capital, LLC 12,203$139,9680.01%
Jump Financial, LLC 18,122$207,8600.01%
JPMORGAN CHASE & CO 4,630,197$53,108,3600.01%
HighTower Advisors, LLC 289,501$3,320,0000.01%
Caption Management, LLC 35,400$406,0380.01%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 40,431$4640.01%
Ameritas Investment Partners, Inc. 8,289$95,0750.00%
MetLife Investment Management, LLC 43,980$504,4510.00%
DENALI ADVISORS LLC 1,100$12,6170.00%
BARCLAYS PLC 534,322$6,1290.00%
Renaissance Technologies 178,500$2,0470.00%
METROPOLITAN LIFE INSURANCE CO/NY 4,832$55,4230.00%
Graham Capital Management, L.P. 10,612$121,7190.00%
AMERICAN INTERNATIONAL GROUP, INC. 41,634$477,5420.00%
Cape Investment Advisory, Inc. 447$5,1270.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.